Clearside Biomedical - Stock Price History | CLSD
Historical daily share price chart and data for Clearside Biomedical since 2021 adjusted for splits. The latest closing stock price for Clearside Biomedical as of October 27, 2021 is 5.26.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
- The all-time high Clearside Biomedical stock closing price was 24.72 on October 11, 2016.
- The Clearside Biomedical 52-week high stock price is 7.73, which is 47% above the current share price.
- The Clearside Biomedical 52-week low stock price is 1.25, which is 76.2% below the current share price.
- The average Clearside Biomedical stock price for the last 52 weeks is 3.82.
|Clearside Biomedical Historical Annual Stock Price Data
||Average Stock Price
||Annual % Change
||Medical - Biomedical and Genetics
Clearside Biomedical, Inc. is a biopharmaceutical company is engaged in developing first-in-class drug therapies to treat blinding diseases of the eye using Clearside proprietary suprachoroidal space(TM) microinjector. Its products include CLS-1001 for the treatment of macular edema associated with non-infectious uveitis; CLS-1003 for the treatment of macular edema associated with retinal vein occlusion; and CLS-1002 program for the treatment of wet age-related macular degeneration. Clearside Biomedical, Inc. is headquartered in Alpharetta, Georgia.